
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.7%, driven by a pullback from Shin Nippon Biomedical Laboratories of 3.2%. In contrast, CellSource has gained 6.1%. The industry has fallen 8.0% in the last year. Earnings are forecast to grow by 14% annually.
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Mar 2026 | JP¥142.9b | JP¥63.3b | -JP¥865,584,000.00 | 21.7x | -165.1x | 2.3x |
| Tue, 17 Feb 2026 | JP¥154.6b | JP¥63.1b | -JP¥1,027,880,000.00 | 22.9x | -150.4x | 2.4x |
| Thu, 15 Jan 2026 | JP¥150.9b | JP¥66.9b | JP¥72.2m | 21.4x | 2090.1x | 2.3x |
| Sat, 13 Dec 2025 | JP¥156.1b | JP¥67.6b | JP¥702.4m | 17.8x | 222.3x | 2.3x |
| Mon, 10 Nov 2025 | JP¥134.5b | JP¥67.6b | JP¥897.4m | 15.6x | 149.8x | 2x |
| Wed, 08 Oct 2025 | JP¥146.8b | JP¥66.5b | JP¥1.5b | 16.6x | 100.6x | 2.2x |
| Fri, 05 Sep 2025 | JP¥148.3b | JP¥66.5b | JP¥1.5b | 16.8x | 101.7x | 2.2x |
| Sun, 03 Aug 2025 | JP¥142.0b | JP¥66.0b | JP¥1.1b | 16.7x | 125.7x | 2.2x |
| Tue, 01 Jul 2025 | JP¥143.1b | JP¥66.0b | JP¥1.1b | 16.3x | 126.7x | 2.2x |
| Thu, 29 May 2025 | JP¥136.9b | JP¥66.0b | JP¥1.1b | 17.3x | 120.9x | 2.1x |
| Sat, 26 Apr 2025 | JP¥135.7b | JP¥64.2b | JP¥1.5b | 14.5x | 88.3x | 2.1x |
| Mon, 24 Mar 2025 | JP¥160.5b | JP¥64.8b | JP¥927.4m | 15.6x | 173.1x | 2.5x |
| Wed, 19 Feb 2025 | JP¥168.5b | JP¥64.9b | JP¥1.4b | 15.8x | 124.6x | 2.6x |
| Fri, 17 Jan 2025 | JP¥162.9b | JP¥62.0b | JP¥440.7m | 17.4x | 369.7x | 2.6x |
| Sun, 15 Dec 2024 | JP¥163.0b | JP¥62.0b | JP¥440.7m | 16.9x | 369.9x | 2.6x |
| Tue, 12 Nov 2024 | JP¥160.4b | JP¥62.6b | JP¥1.3b | 21.5x | 120.7x | 2.6x |
| Thu, 10 Oct 2024 | JP¥154.4b | JP¥61.5b | JP¥1.8b | 17.8x | 83.9x | 2.5x |
| Sat, 07 Sep 2024 | JP¥156.3b | JP¥61.5b | JP¥2.1b | 18.6x | 74.1x | 2.5x |
| Mon, 05 Aug 2024 | JP¥149.3b | JP¥61.8b | JP¥3.2b | 21.9x | 46.1x | 2.4x |
| Wed, 03 Jul 2024 | JP¥165.6b | JP¥61.8b | JP¥3.2b | 25.8x | 51.2x | 2.7x |
| Fri, 31 May 2024 | JP¥158.7b | JP¥61.8b | JP¥3.3b | 24.5x | 48.5x | 2.6x |
| Sun, 28 Apr 2024 | JP¥180.4b | JP¥62.3b | JP¥3.3b | 14.1x | 54.8x | 2.9x |
| Tue, 26 Mar 2024 | JP¥231.5b | JP¥155.4b | JP¥8.6b | 14x | 26.9x | 1.5x |
| Thu, 22 Feb 2024 | JP¥233.7b | JP¥155.3b | JP¥8.7b | 14.9x | 26.9x | 1.5x |
| Sat, 20 Jan 2024 | JP¥224.2b | JP¥167.1b | JP¥8.5b | 15.2x | 26.4x | 1.3x |
| Mon, 18 Dec 2023 | JP¥229.5b | JP¥167.1b | JP¥8.5b | 14.8x | 27x | 1.4x |
| Wed, 15 Nov 2023 | JP¥230.0b | JP¥168.1b | JP¥9.1b | 14.7x | 25.3x | 1.4x |
| Fri, 13 Oct 2023 | JP¥239.3b | JP¥179.3b | JP¥12.8b | 15x | 18.7x | 1.3x |
| Sun, 10 Sep 2023 | JP¥264.9b | JP¥179.3b | JP¥12.8b | 16.6x | 20.7x | 1.5x |
| Tue, 08 Aug 2023 | JP¥278.4b | JP¥179.8b | JP¥13.7b | 18.4x | 20.3x | 1.5x |
| Thu, 06 Jul 2023 | JP¥278.7b | JP¥178.5b | JP¥16.2b | 17x | 17.2x | 1.6x |
| Sat, 03 Jun 2023 | JP¥290.0b | JP¥178.3b | JP¥16.2b | 17x | 17.9x | 1.6x |
| Mon, 01 May 2023 | JP¥286.2b | JP¥174.9b | JP¥16.5b | 16.5x | 17.4x | 1.6x |
| Wed, 29 Mar 2023 | JP¥309.1b | JP¥171.9b | JP¥13.3b | 16.5x | 23.3x | 1.8x |
23.3x
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | -0.63% | |
| Healthcare | -1.54% | |
| Life Sciences | -1.71% | |
| Clinical Research and Equipment | -1.71% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4880 CellSource | JP¥401.00 | 6.1% +JP¥456.5m | -50.0% | PE90x | |
| 7707 Precision System Science | JP¥225.00 | 4.7% +JP¥274.6m | -2.6% | PS1.2x | |
| 4572 Carna Biosciences | JP¥351.00 | 3.2% +JP¥211.0m | 23.6% | PS11.6x | |
| 130A Veritas In Silico | JP¥475.00 | 1.7% +JP¥51.9m | -42.5% | PS33.8x | |
| 6190 PhoenixBio | JP¥455.00 | 1.8% +JP¥32.6m | 18.2% | PS1.2x |